Garvey W T, Huecksteadt T P, Matthaei S, Olefsky J M
Department of Medicine, University of California San Diego School of Medicine, La Jolla 92093.
J Clin Invest. 1988 May;81(5):1528-36. doi: 10.1172/JCI113485.
To examine the role of glucose transport proteins in cellular insulin resistance, we studied subcutaneous adipocytes isolated from lean control, obese control (body mass index [BMI] 33.4 +/- 0.9), and untreated obese non-insulin-dependent diabetes mellitus (NIDDM) patients (BMI 35.2 +/- 2.1; fasting glucose 269 +/- 20 mg/dl). Glucose transporters were measured in plasma membrane (PM), low-density (LDM), and high-density (HDM) microsomal subfractions from basal and maximally insulin-stimulated cells using the cytochalasin B binding assay, and normalized per milligram of membrane protein. In all subgroups, insulin led to an increase in PM glucose transporters and a corresponding depletion of transporters in the LDM. Insulin recruited 20% fewer transporters to the PM in the obese subgroup when compared with lean controls, and this was associated with a decline in LDM transporters with enlarging cell size in the control subjects. In NIDDM, PM, and LDM, transporters were decreased 50% in both basal and stimulated cells when compared with obese controls having similar mean adipocyte size. Cellular depletion of glucose transporters was not the only cause of insulin resistance, because the decrease in rates of [14C]-D-glucose transport (basal and insulin-stimulated) was greater than could be explained by reduced numbers of PM transporters in both NIDDM and obesity. In HDM, the number of transporters was not influenced by insulin and was similar in all subgroups. We conclude that (a) in NIDDM and obesity, both reduced numbers and impaired activity of glucose transporters contribute to cellular insulin resistance, and (b) in NIDDM, more profound cellular insulin resistance is associated primarily with a further depletion of cellular transporters.
为研究葡萄糖转运蛋白在细胞胰岛素抵抗中的作用,我们研究了从瘦素对照组、肥胖对照组(体重指数[BMI] 33.4±0.9)和未经治疗的肥胖非胰岛素依赖型糖尿病(NIDDM)患者(BMI 35.2±2.1;空腹血糖269±20mg/dl)分离出的皮下脂肪细胞。使用细胞松弛素B结合试验,在基础状态和最大胰岛素刺激状态下的细胞膜(PM)、低密度(LDM)和高密度(HDM)微粒体亚组分中测量葡萄糖转运蛋白,并以每毫克膜蛋白进行标准化。在所有亚组中,胰岛素导致PM葡萄糖转运蛋白增加,同时LDM中转运蛋白相应减少。与瘦素对照组相比,肥胖亚组中胰岛素募集到PM的转运蛋白减少了20%,这与对照组中随着细胞大小增大LDM转运蛋白的减少有关。在NIDDM患者中,与平均脂肪细胞大小相似的肥胖对照组相比,基础状态和刺激状态下的细胞中,PM和LDM中的转运蛋白均减少了50%。葡萄糖转运蛋白的细胞内减少并非胰岛素抵抗的唯一原因,因为在NIDDM和肥胖症中,[14C]-D-葡萄糖转运速率(基础状态和胰岛素刺激状态)的降低幅度大于PM转运蛋白数量减少所能解释的范围。在HDM中,转运蛋白的数量不受胰岛素影响,且在所有亚组中相似。我们得出结论:(a)在NIDDM和肥胖症中;葡萄糖转运蛋白数量减少和活性受损均导致细胞胰岛素抵抗;(b)在NIDDM中,更严重的细胞胰岛素抵抗主要与细胞内转运蛋白的进一步减少有关。